Related Experiment Video
Updated: Mar 14, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
Stephen T Schultz1, Georgianna G Gould1
1Department of Physiology, School of Medicine, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Insights
Acetaminophen use in early childhood is linked to Autism Spectrum Disorder (ASD). This study suggests a reversed association in older children and explores potential endocannabinoid system links, recommending safety reviews for acetaminophen.
Area of Science:
- Neurodevelopmental disorders
- Pediatric pharmacology
- Endocannabinoid system research
Background:
- Autism Spectrum Disorder (ASD) presents with social communication deficits and restricted behaviors.
- Previous research indicated a link between early acetaminophen use and increased ASD likelihood.
- This study investigates the association in older children and explores underlying mechanisms.
Purpose of the Study:
- To re-examine the association between acetaminophen use and ASD in older children.
- To investigate the shift in medication preference (acetaminophen vs. ibuprofen) in children with ASD.
- To explore the potential role of the endocannabinoid system in observed associations.
Main Methods:
- Case-control study comparing children with and without ASD.
- Analysis of medication use patterns, including acetaminophen and ibuprofen.
- Examination of sociability changes during fever in relation to medication use.
Main Results:
- Acetaminophen use showed a reversed association with ASD in older children compared to younger ones.
- Children with ASD were more likely to switch from acetaminophen to ibuprofen for fever management.
- Children with ASD exhibited increased sociability during fevers, potentially linked to endocannabinoid system activation.
Conclusions:
- Acetaminophen use in early life may be associated with altered endocannabinoid system function in ASD.
- The findings suggest a need for further investigation into the safety of acetaminophen in pediatric populations.
- Understanding these associations may inform future research and clinical recommendations regarding medication use in children at risk for ASD.
Abstract:
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication and restrictive behavior, interests, and activities. Our previous case-control study showed that use of acetaminophen at age 12-18 months is associated with increased likelihood for ASD (OR 8.37, 95% CI 2.08-33.7). In this study, we again show that acetaminophen use is associated with ASD (p = 0.013). Because these children are older than in our first study, the association is reversed; fewer children with ASD vs. non-ASD children use acetaminophen as a "first choice" compared to "never use" (OR 0.165, 95% CI 0.045, 0.599). We found significantly more children with ASD vs. non- ASD children change to the use of ibuprofen when acetaminophen is not effective at reducing fever (p = 0.033) and theorize this change in use is due to endocannabinoid system dysfunction. We also found that children with ASD vs. non-ASD children are significantly more likely to show an increase in sociability when they have a fever (p = 0.037) and theorize that this increase is due to anandamide activation of the endocannabinoid system in ASD children with low endocannabinoid tone from early acetaminophen use. In light of this we recommend that acetaminophen use be reviewed for safety in children.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion

